Product

Milagen is developing novel diagnostic products for early detection and therapy management. These novel products for cancer and major diseases are non-invasive and easy-to-use .

Product Pipeline

Milagen’s first product pipeline includes several immunoassays with high sensitivity and specificity for the early detection of early stage localized cancers. We have several products in late stage development for the early detection and diagnosis of the following diseases:

Milagen anticipates to offer its novel diagnostic products directly to patients and through diagnostic and reference laboratories for the early detection of a major cancer.

 

Disease Discovery   Validation     Blind Validation     Home-brew     Reagents for final products  
Lung Cancer        
Colon Cancer        
Prostate Cancer                      
Ovarian Cancer               
Pancreatic Cancer           
Breast Cancer            
Diabetes Type II            
Asthma